2026 data FDA MAUDE openFDA

Enzymatic Method, Creatinine

Adverse-event figures are drawn from the U.S. Food & Drug Administration (FDA) MAUDE database, refreshed March 2026, see our methodology.

OpenFDA device adverse-event casebook.

FDA MAUDE casebook

openFDA event book Enzymatic Method, Creatinine LIGHT-BOOK · MAUDE

#851 of 1000 · 533 reports · 1997–2026

  • BOOK 533 reports
  • RANK #851 of 1000
  • DEATH 0 death-typed
  • INJ 14 injury-typed
  • MALF 518 malfunction
  • SPAN 1997–2026
  • PEAK 2025: 61
  • PHOTO Accessories

Nearest event-volume peer: Accessories, Pump, Infusion (0 report gap)

Enzymatic Method, Creatinine sits #851 of 1000 among tracked device types with 533 MAUDE reports spanning 1997–2026. Rank counts report volume, not confirmed device fault. Event_type Death / Injury / Malfunction are one code per report — not the same population as patient-outcome rows ( methodology). Read with this device → · Lead manufacturer → · Similar-volume device →

Event-type mix vs corpus

Shares of FDA event_type codes on this device type, compared with the mean across 1,000 device types that have ≥100 MAUDE reports. Codes are report labels, not adjudicated causation.

  • DEATH 0.0% corpus 1.5% · below corpus mean (-1.5 pp)
  • INJ 2.6% corpus 30.4% · below corpus mean (-27.8 pp)
  • MALF 97.2% corpus 64.5% · above corpus mean (+32.7 pp)

Lead product-problem code Low Test Results is 29% of coded problems · Lead manufacturer ROCHE DIAGNOSTICS accounts for 45% of manufacturer-tagged reports · Top event location is 48% of location-tagged rows .

Enzymatic Method, Creatinine in the event-volume neighbourhood

FDA MAUDE report totals among this device type and nearest nationwide peers

reports

What this shows Enzymatic Method, Creatinine carries 533 MAUDE reports, ranked #851 of 1000.

Source FDA MAUDE via openFDA, aggregated by PlainHospital As of August 2026

Event Types

Malfunction 518 (97.2%)
Injury 14 (2.6%)
Other 1 (0.2%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

513 (96.2%)
Other 14 (2.6%)
Hospitalization 4 (0.8%)
Required Intervention 2 (0.4%)

Top Product Problems

Low Test Results 119
High Test Results 117
Non Reproducible Results 56
Incorrect, Inadequate or Imprecise Result or Readings 39
No Apparent Adverse Event 20
Adverse Event Without Identified Device or Use Problem 16
High Readings 12
Insufficient Information 7
Appropriate Term/Code Not Available 6
Incorrect Measurement 6
Incorrect Or Inadequate Test Results 4
Low Readings 2
Output Problem 2
Device Ingredient or Reagent Problem 1
Imprecision 1
No Device Output 1
Nonstandard Device 1
Unable to Obtain Readings 1

Yearly Trend

97
1997: 1
00
2000: 4
01
2001: 1
03
2003: 1
05
2005: 2
07
2007: 1
08
2008: 4
09
2009: 22
10
2010: 22
11
2011: 42
12
2012: 24
13
2013: 39
14
2014: 4
15
2015: 7
16
2016: 16
17
2017: 16
18
2018: 34
19
2019: 56
20
2020: 34
21
2021: 57
22
2022: 9
23
2023: 36
24
2024: 34
25
2025: 61
26
2026: 6

Related Entities for Enzymatic Method, Creatinine

Event Locations

254 (47.7%)
I 217 (40.7%)
LABORATORY 44 (8.3%)
OTHER 8 (1.5%)
NOT APPLICABLE 6 (1.1%)
OUTPATIENT TREATMENT FACILITY 2 (0.4%)
INVALID DATA 1 (0.2%)
RADIOLOGY DEPARTMENT 1 (0.2%)

Compare ROCHE DIAGNOSTICS vs ORTHO-CLINICAL DIAGNOSTICS →

Nationwide devices with similar MAUDE profiles

Two openFDA-derived peer sets for Enzymatic Method, Creatinine, both floored at ≥100 reports so the neighborhoods stay in the advertised mass.

Similar report volume

Nearest other device types by FDA MAUDE report count (533 here).

Similar death-typed counts

Nearest other device types by death-typed report count (0 here), distinct from the volume row.

Disclaimer: MAUDE figures for Enzymatic Method, Creatinine are informational only and are not clinical advice. Report codes do not prove device causation. Consult a qualified clinician before acting on this data.

Every figure on PlainHospital is rendered directly from federal source data, no number is typed in by an editor. Event-type mix on this page is computed from FDA MAUDE codes for Enzymatic Method, Creatinine; corpus means use device types with ≥100 reports. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.